Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc.
- Market cap
- $5.60M
Your view on TVGNW
Overview
What the company does, where it operates, and who runs it.
About Tevogen Bio Holdings Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Ryan H. Saadi
- Headquarters
- 15 Independence Blvd, Warren, NJ, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Ryan H. Saadi
- Headquarters
- 15 Independence Blvd, Warren, NJ, US
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions.
The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Tevogen Bio Holdings Inc.. Starting points for Tevogen Bio Holdings Inc.: EPS -$5.59, beta 0.22 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Tevogen Bio Holdings Inc.. Trailing twelve-month EPS for Tevogen Bio Holdings Inc. stands at -$5.59. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Tevogen Bio Holdings Inc.. Tevogen Bio Holdings Inc. has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BDTXBlack Diamond Therapeutics, Inc. | Healthcare | NASDAQ | $75.3M | ||
| BEAMBeam Therapeutics Inc. | Healthcare | NASDAQ | $2.2B | ||
| BETR.CNBetterLife Pharma Inc. | Healthcare | CNQ | — | ||
| BETRFBetterLife Pharma Inc. | Healthcare | OTC | $6.4M | ||
| BHVNBiohaven Ltd. | Healthcare | NYSE | $1.9B | ||
| BICTFBiocure Technology Inc. | Healthcare | OTC | $379,088 | ||
| BIOABioAge Labs, Inc. | Healthcare | NASDAQ | $161.1M | ||
| BIOAFBioasis Technologies Inc. | Healthcare | OTC | $15,883 | ||
| BIORQBiora Therapeutics, Inc. | Healthcare | PNK | — | ||
| BIT.AXBiotron Limited | Healthcare | ASX | — | ||
| BITRFBiotron Limited | Healthcare | OTC | $29.2M | ||
| BIVIBioVie Inc. | Healthcare | NASDAQ | $8.6M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Tevogen Bio Holdings Inc., and how their positions are changing. At a $5.6M market value, institutional positions materially move Tevogen Bio Holdings Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Tevogen Bio Holdings Inc. executives and directors. Shares of Tevogen Bio Holdings Inc. have traded between $0.04 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Tevogen Bio Holdings Inc.. Coverage tracks Tevogen Bio Holdings Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Tevogen Bio Holdings Inc.